002294.SZ
信立泰
SZSE · Healthcare · C 制造业 · CN
CNY 31.62
−3.24%Year over year
Reported trailing growth
- Revenue
- +13.4%
- EBITDA
- —
- EBIT
- +10.2%
- EPS
- +11.7%
- Free cash flow
- -93.0%
- Operating cash flow
- -5.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +7.7%
- EBITDA
- +1.3%
- EBIT
- -2.1%
- Net income
- +0.7%
- EPS
- +0.0%
- Free cash flow
- -40.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026